oseltamivir has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, S; Nisijima, K; Shioda, K; Yoshino, T; Yui, K | 1 |
1 other study(ies) available for oseltamivir and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
Oseltamivir (Tamiflu) increases dopamine levels in the rat medial prefrontal cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Antiviral Agents; Dopamine; Enzyme Inhibitors; Extracellular Fluid; Homovanillic Acid; Male; Mental Disorders; Microdialysis; Oseltamivir; Prefrontal Cortex; Rats; Rats, Wistar; Serotonin; Synaptic Transmission; Up-Regulation | 2008 |